- MRNA stock falls as equities sell-off on bond yields.
- Moderna is due to report earnings on November 3.
- Moderna gets EMA approval for expanded use of its covid vaccine.
Modena (MRNA) stock fell sharply on Wednesday when it closed at $123.84 for a loss of nearly 8%. The move seems curious and exceeds that of peer Pfizer (PFE) and Novavax for example.
Moderna stock news
Moderna on Wednesday got a recommendation from the European Medicines Agency (EMA) for expanded use in those aged 12 and older for Moderna's adapted covid vaccine, which targets subvariants of Omicron. The adapted vaccine targets new strains BA.4 and BA.5 and is recommended for those who are already vaccinated. Also, the US CDC voted in favor of including covid vaccines already approved for children into the federally funded Vaccines for Children program. This provides free vaccines to children whose parents may not be able to afford the vaccines.
Moderna stock forecast
Moderna has fallen significantly in 2022 and has attempted to form a bottom on several occasions. We can see from the highlighted area how well $120 has worked as support as this sell-off again has targeted the $120 zone of support. Earnings could provide the next catalysts as investors look for alternative revenue streams as covid hopefully winds down and exits stage left. Good riddance! Recent news of a deal to jointly develop a cancer vaccine between Moderna and Merck was well-received by the market. Investors will look for more information in the earnings call.
Holding $120 would see $143.80 as the first resistance and then $152 from the 200-day moving average.
Moderna daily chart
On the weekly chart below we can see just how key this $120 support is. Beneath is a volume gap until $80!
Moderna weekly chart
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD sits at yearly lows near 1.0550 ahead of EU GDP, US PPI data
EUR/USD is trading near 1.0550 in the European session on Thursday, sitting at the lowest level in a year. The Trump trades-driven relentless US Dollar buying and German political instability weigh on the pair. Traders await EU GDP data and US PPI report ahead of Fed Chair Powell's speech.
GBP/USD holds losses below 1.2700 on sustained US Dollar strength
GBP/USD is holding losses near multi-month lows below 1.2700 in European trading on Thursday. The pair remains vulnerable amid a broadly firmer US Dollar and softer risk tone even as BoE policymakers stick to a cautious stance on policy. Speeches from Powell and Bailey are eyed.
Gold price hits fresh two-month low as the post-election USD rally remains uninterrupted
Gold price drifts lower for the fifth consecutive day and drops to its lowest level since September 19, around the $2,554-2,553 region heading into the European session on Thursday. The commodity continues to be weighed down by an extension of the US Dollar's post-election rally to a fresh year-to-date.
XRP struggles near $0.7440, could still sustain rally after Robinhood listing
Ripple's XRP is trading near $0.6900, down nearly 3% on Wednesday, as declining open interest could extend its price correction. However, other on-chain metrics point to a long-term bullish setup.
Trump vs CPI
US CPI for October was exactly in line with expectations. The headline rate of CPI rose to 2.6% YoY from 2.4% YoY in September. The core rate remained steady at 3.3%. The detail of the report shows that the shelter index rose by 0.4% on the month, which accounted for 50% of the increase in all items on a monthly basis.
Best Forex Brokers with Low Spreads
VERIFIED Low spreads are crucial for reducing trading costs. Explore top Forex brokers offering competitive spreads and high leverage. Compare options for EUR/USD, GBP/USD, USD/JPY, and Gold.